The COVID-19 pandemic has disproportionately affected more vulnerable populations, including those living with dementia. Over 50 million individuals worldwide are living with Alzheimer's disease (AD) or other dementia, and it is crucial to continue the fight against the condition during the global pandemic. Since the start of mandated lockdowns in March 2020, charity and non-profit organizations that fund AD and related dementia research continue to respond to the needs of the AD research community, ensuring the momentum continues and accelerates. Members of the International Alzheimer's and Related Dementia Research Funder Consortium, a group of nearly 40 funding organizations that informally convene throughout the year to share updates and information, have taken a number of steps to ensure the continued support of the research community. Even during times of uncertainty, it is essential that the field moves forward to uncover preventions, diagnoses, and treatments for these diseases that affect many millions globally.

中文翻译：

---

评论：全球阿尔茨海默病和阿尔茨海默病相关的痴呆症研究资助组织在整个 COVID-19 大流行期间支持和参与研究界

COVID-19 大流行不成比例地影响了更脆弱的人群，包括痴呆症患者。全世界有超过 5000 万人患有阿尔茨海默病 (AD) 或其他痴呆症，在全球大流行期间继续与这种疾病作斗争至关重要。自 2020 年 3 月开始强制封锁以来，资助 AD 和相关痴呆症研究的慈善和非营利组织继续响应 AD 研究界的需求，确保势头持续并加速。国际阿尔茨海默氏症和相关痴呆症研究资助者联盟的成员由近 40 个资助组织组成，全年非正式地召开会议以分享更新和信息，已采取一系列措施确保研究界的持续支持。